Early research (Phase 1)Study completedNCT03177460
What this trial is testing
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 33